Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms STRIP
- 28 Aug 2017 Planned End Date changed from 1 Oct 2016 to 1 Dec 2018.
- 28 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated